Skip to main content
Devonian Health Group Inc logo

Devonian Health Group Inc — Investor Relations & Filings

Ticker · GSD TSXV Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2026-02-17 Regulatory Filings
Country CA Canada
Listing TSXV GSD

About Devonian Health Group Inc

https://groupedevonian.com/

Devonian Health Group Inc. is a clinical-stage botanical pharmaceutical company specializing in the development of novel prescription therapeutic solutions for unmet medical needs. The core business involves late-stage prescription botanical drugs targeting fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. The company utilizes a broad-based technology platform, originating from over 20 years of research, to develop therapies that target multiple cellular pathways and regulate genes linked to these diseases. Its pipeline includes the lead product candidate, Thykamine, currently in Phase 3 clinical trials. Devonian also develops high-value dermatological products alongside its core drug development activities.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109FV2 Certification of Interim Filings', which is an officer certification/attestation document. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like an interim report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q1 2023
2026-02-17 English
News release - French.pdf
Board/Management Information Classification · 1% confidence The document is a press release from Groupe Santé Devonian Inc. announcing the appointment of a new Chief Financial Officer (Dennis Turpin) and providing a correction regarding previously issued stock options. The document focuses on management changes and capital structure adjustments (stock options and share consolidation). According to the filing definitions, announcements regarding changes in senior management fall under 'MANG' (Board/Management Information). While it also discusses stock options, the primary news event is the executive appointment.
2026-02-02 French
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of a new Chief Financial Officer (Dennis Turpin) and providing updates regarding stock option grants and corrections to previous disclosures. Since the primary content concerns changes in senior management and updates to equity-based compensation/capital structure, it falls under the 'Board/Management Information' category.
2026-02-02 English
Notice of the meeting and record date (amended) - French.pdf
AGM Information Classification · 1% confidence The document is a formal notice from TSX Trust Company regarding the upcoming Annual General Meeting (AGM) for Groupe Santé Devonian Inc. It specifies the meeting date, record dates for notice and voting, and confirms the transmission of these details to regulatory bodies. This is a standard administrative notification regarding the scheduling of a shareholder meeting, which falls under the category of Regulatory Filings (RNS) as it is a procedural notice rather than the proxy materials themselves or the meeting presentation.
2026-01-28 French
Notice of the meeting and record date (amended) - English.pdf
AGM Information Classification · 1% confidence The document is a formal notice from TSX Trust Company regarding the upcoming Annual General and Special Meeting for Devonian Health Group Inc. It specifies the record date, meeting date, and details regarding proxy-related materials and voting rights. This type of document is a standard communication sent to regulators and exchanges to announce the logistics of an upcoming shareholder meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it pertains to the preparation and solicitation process for a meeting.
2026-01-28 English
Certificate and Articles of Amendment.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a 'Certificate of Amendment' and 'Form 4' filed with Corporations Canada, detailing a share consolidation (reverse stock split) for Devonian Health Group Inc. Since this document describes a change in the company's capital structure (share consolidation), it falls under the category of share/capital changes.
2026-01-22 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.